U.S. Pharma Stock News

If you are wondering whether NIO's current share price reflects its true worth, you are not alone. This article focuses on what the numbers say about value rather than the hype. NIO's stock recently closed at US$5.55, with returns of 17.6% over the last 7 days, 11.9% over 30 days, 8.0% year to date. However, longer term returns of 17.3% over 1 year, a 34.7% decline over 3 years, and an 86.7% decline over 5 years give a very different picture of the journey so far. Recent coverage of NIO has...

Voyager Therapeutics, Inc. recently reported fourth-quarter 2025 results showing a net loss of US$27.43 million, improving from US$34.49 million a year earlier, while its full-year 2025 net loss widened to US$119.72 million from US$65.00 million in 2024. Although Voyager reduced its quarterly loss per share, the much larger full-year loss highlights the cost intensity of advancing its neurological disease pipeline. We’ll now examine how Voyager’s improved quarterly loss but much larger...

Zurn Elkay Water Solutions (NYSE:ZWS) reported record annual performance with double digit core sales growth. The company highlighted improved operating margins over the year. Management announced a substantial increase in its dividend. The company also disclosed a significant share repurchase program. Zurn Elkay Water Solutions focuses on water management products and systems, an area that sits at the intersection of infrastructure, building construction, and resource efficiency. With...

Digimarc (DMRC) has just posted its FY 2025 numbers, with Q4 revenue of US$8.9 million, a basic EPS loss of US$0.19, and net income excluding extra items showing a loss of US$4.2 million, setting the tone for how investors will read the full year. Over recent quarters, the company has seen revenue move between US$7.6 million and US$9.4 million while quarterly EPS losses ranged from US$0.19 to US$0.55, giving a clear picture of a business that is still loss making but working through its cost...

If you are wondering whether BioNTech's current share price lines up with its long term potential, starting with a clear look at valuation can help you frame that question more calmly. BioNTech's shares recently closed at US$90.10, with returns of 11.6% decline over the past week, 17.3% decline over the last month, and 6.8% decline year to date, alongside 7.6% decline over 1 year, 31.7% decline over 3 years, and 12.2% decline over 5 years, which hints that the market's view on risk and...

In recent weeks, AMETEK reported quarterly results that exceeded analyst expectations, raised its full-year guidance, and approved a 10% increase in its quarterly cash dividend, while continuing to invest heavily in growth projects. These developments, coupled with long-term institutional backing from investors like GAMCO and increased interest from hedge funds, highlight how AMETEK’s earnings momentum and capital allocation policies are shaping perceptions of its quality and...

Montauk Renewables (MNTK) closed out FY 2025 with Q4 revenue of US$43.4 million and basic EPS of US$0.02 on net income of US$2.5 million, setting the tone for a year where reported earnings and margins were under close watch. The company has seen quarterly revenue move from US$27.7 million and basic EPS of US$0.06 in Q4 2024 to a mix of losses and profits through 2025, including Q2 revenue of US$45.1 million with a loss of US$5.5 million and basic EPS of US$0.04, before landing on US$45.3...

Why DaVita (DVA) is back in the spotlight DaVita (DVA) is back under the microscope after recent analyst reports flagged flat treatment volumes, slower expected sales growth, and pressure on free cash flow margins, even as some ratings remain very positive. See our latest analysis for DaVita. DaVita’s share price has moved to US$153.06, with a 9.9% 1 month share price return and 26.1% 3 month share price return. Its 3 year total shareholder return of 96.2% contrasts with recent concerns over...

Velocity Financial FY 2025 results in focus Velocity Financial (VEL) has wrapped up FY 2025 with fourth quarter total revenue of US$57.1 million and basic EPS of US$0.89, setting the tone for how investors will read the full year. The company has seen quarterly revenue move from US$84.9 million in Q4 2024 to US$57.1 million in Q4 2025, while basic EPS shifted from US$0.62 to US$0.89 over the same period, and on a trailing twelve month basis EPS stands at US$2.81 on revenue of US$183.5...

Oil-Dri Corporation of America (ODC) has just posted Q2 2026 results with revenue of US$117.7 million and basic EPS of US$0.87, alongside trailing twelve month EPS of US$3.62 on revenue of US$478.9 million. Over recent quarters the company has seen revenue move between US$116.9 million and US$127.9 million, while quarterly EPS has ranged from US$0.80 to US$1.13. This sets up a picture of steady top line and earnings performance that now sits on the back of 15.6% earnings growth over the past...

Sleep Number (SNBR) has capped FY 2025 with fourth quarter revenue of US$347.4 million and a basic EPS loss of US$2.55, as net income excluding extra items came in at a loss of US$58.5 million. The company has seen quarterly revenue move from US$393.3 million in Q1 2025 to US$327.9 million in Q2, US$342.9 million in Q3 and US$347.4 million in Q4, alongside a widening basic EPS loss over the same stretch. For investors, that mix of steady sales levels and deeper losses keeps the focus firmly...

Frequency Electronics (FEIM) has just posted Q3 2026 results with revenue of US$16.9 million, basic EPS of US$0.16 and net income of US$1.6 million. This comes in a year where trailing 12 month revenue sits at US$67.8 million and EPS at US$0.74. Over recent quarters the company has seen revenue move from US$18.9 million in Q3 2025 to US$19.0 million in Q4 2025, then US$13.8 million, US$17.1 million and now US$16.9 million. Basic EPS shifted from US$1.60 to US$0.33, US$0.07, US$0.18 and...

Q32 Bio (QTTB) has just posted its FY 2025 numbers, reporting fourth quarter revenue of US$53.7 million and basic EPS of US$4.60, alongside trailing 12 month basic EPS of US$2.42 and net income of US$29.8 million. The company’s quarterly revenue has moved from US$0 and a basic EPS loss of US$1.16 in Q4 2024 to US$53.7 million and US$4.60 in Q4 2025. Interim 2025 quarters showed no revenue and basic EPS losses between US$0.60 and US$0.90, so investors will likely focus on how durable these...

Futu Holdings (NasdaqGM:FUTU) has capped FY 2025 with fourth quarter revenue of HK$6.0b and basic EPS of HK$24.31, set against trailing twelve month EPS of HK$81.39 on revenue of HK$21.1b and year over year earnings growth of 120.7%. Over recent periods the company has seen quarterly revenue move from HK$3.9b and EPS of HK$13.54 in Q4 2024 to HK$6.0b and EPS of HK$24.31 in Q4 2025, while trailing net profit margin sits at 51.7% compared with 43.8% in the prior year. For investors, this...

IDT (IDT) has just posted Q2 2026 numbers with total revenue of US$320.5 million and basic EPS of US$0.84, alongside net income excluding extra items of US$20.9 million. This puts fresh detail around its earnings profile. The company has seen quarterly revenue move between US$301.9 million and US$322.8 million over the last six reported periods, while basic EPS has ranged from US$0.68 to US$0.89. This gives investors a clearer view of how sales and per share profits have been tracking into...

Aemetis (AMTX) has wrapped up FY 2025 with Q4 revenue of US$53.7 million and a basic EPS loss of US$0.08, alongside trailing 12 month revenue of US$197.6 million and a cumulative net loss of US$77.0 million. Over recent quarters, the company has seen quarterly revenue move between US$42.9 million and US$59.2 million, while basic EPS losses ranged from US$0.47 to US$0.08. This latest print keeps the focus squarely on how quickly margins can tighten up from here. See our full analysis for...

Ollie's Bargain Outlet Holdings (OLLI) just wrapped up FY 2026 with fourth quarter revenue of US$779.3 million and basic EPS of US$1.40, alongside net income of US$85.6 million, while trailing twelve month revenue came in at about US$2.6 billion with basic EPS of US$3.92. Over recent quarters the company has seen quarterly revenue move from US$517.4 million in Q3 FY 2025 to US$613.6 million in Q3 FY 2026 and from US$667.1 million in Q4 FY 2025 to US$779.3 million in Q4 FY 2026. EPS shifted...

Verrica Pharmaceuticals (VRCA) just closed out FY 2025 with Q4 revenue of US$5.1 million and a basic EPS loss of US$0.57, alongside trailing 12 month revenue of US$35.6 million and a basic EPS loss of US$1.68. Over the past few quarters, the company has seen revenue move from US$3.4 million in Q1 2025 to US$12.7 million in Q2 and US$14.3 million in Q3, while quarterly basic EPS has ranged from a loss of US$1.03 in Q1 to a small profit of US$0.02 in Q2 and a near breakeven loss of US$0.03 in...

MongoDB (MDB) has just wrapped up FY 2026 with Q4 revenue of US$695.1 million and basic EPS of US$0.19, alongside trailing 12 month revenue of US$2.5 billion and a trailing basic EPS loss of US$0.88. Over recent quarters the company has seen revenue move from US$549.0 million in Q1 FY 2026 to US$695.1 million in Q4, while quarterly basic EPS has ranged from a loss of US$0.58 in Q2 to a profit of US$0.19 in Q4. This sets up a results season where investors are likely to focus on how improving...

Sunrise Realty Trust (SUNS) has just wrapped up FY 2025 with fourth quarter revenue of US$3.6 million and basic EPS of US$0.12, alongside trailing twelve month EPS of US$0.93 on revenue of US$19.5 million and year over year earnings growth of 73.2%. Over the past year, the company has seen quarterly revenue range from US$3.6 million to US$6.3 million, with basic EPS moving between US$0.12 and US$0.30. Trailing twelve month figures indicate that analysts are currently forecasting earnings...

Chicago Atlantic Real Estate Finance (REFI) has wrapped up FY 2025 with fourth quarter total revenue of US$14.1 million and basic EPS of US$0.39, giving investors fresh numbers to weigh against its high headline yield and recent margin trends. The company has seen quarterly revenue move between US$13.1 million and US$15.4 million over the last six reported periods, while basic EPS ranged from US$0.39 to US$0.57 over the same timeframe. This sets a clear frame of reference for the latest print...

LifeMD (LFMD) is back in focus after its latest earnings, where the telehealth provider reported full year 2025 net income of US$14.35 million and issued fresh 2026 revenue guidance. See our latest analysis for LifeMD. LifeMD’s latest earnings and 2026 guidance have arrived after a sharp recent move, with a 7 day share price return of 31.17% and a 30 day share price return of 29.02% despite a 1 year total shareholder return decline of 30.48%. Short term momentum is building, while the longer...

Dollar General (DG) just wrapped up FY 2026 with fourth quarter revenue of US$10.9b and basic EPS of US$1.94, alongside net income of US$426.3m that will be front and center for investors parsing the latest release. The company has seen quarterly revenue move from US$10.3b in Q4 FY 2025 to US$10.9b in Q4 FY 2026, while basic EPS shifted from US$0.87 to US$1.94 over the same period. This sets up a results season in which attention will fall heavily on how those earnings translate into margins...

Globe Life Inc. recently expanded its Board of Directors from twelve to fourteen members, appointing Derek T. Kan to the Audit Committee and Sandra L. Phillips to the Governance and Nominating Committee, while also approving a higher quarterly dividend of US$0.33 per share payable on May 1, 2026 to shareholders of record on April 3, 2026. Together, the Board expansion and dividend increase underscore the company’s focus on governance depth and consistent cash returns as key pillars of its...